A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

Finally, the ability of new-generation ICMs to automatically record arrhythmic episodes suggests that these devices could also be used to study asymptomatic ... 1): from bradycardia to asystole ...

SND and bradycardia-tachycardia are very common conditions in ... are influenced by symptomatic patients (NYHA II or III); there is insufficient evidence on asymptomatic patients (NYHA I). In the ...

In contrast, “device-detected subclinical AF” includes asymptomatic episodes detected by implantable ... Other possible indications include its use in patients with AF-related bradycardia or pauses ...

Two strategies to manage asymptomatic severe AS are typically performed; clinical surveillance (CS), with routine monitoring and aortic valve replacement only when symptoms developed, or aortic ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.

The US Food and Drug Administration (FDA) has approved Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for the treatment of patients with asymptomatic severe ...

Asymptomatic patients with severe aortic stenosis can now undergo transcatheter aortic valve replacement, thanks to the US Food and Drug Administration’s approval of the new indication for the balloon ...

Approval of the SAPIEN 3 platform (SAPIEN 3, SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA) is based on groundbreaking data from the EARLY TAVR trial, which demonstrated that asymptomatic severe AS ...

In that trial, among 901 people over age 65 with asymptomatic severe aortic stenosis, low surgical risk, and preserved left ventricular ejection fraction (LVEF), upfront TAVR resulted in fewer ...